Related Experiment Video
Updated: Jul 27, 2025

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
Published on: October 24, 2018
Hemostatic disorders associated with extracorporeal membrane oxygenation
Martin Mirus1, Lars Heubner1, Johannes Kalbhenn2
1Department of Anesthesiology and Intensive Care Medicine, University Hospital Dresden, Technische Universität Dresden, Dresden, Germany.
Extracorporeal membrane oxygenation (ECMO) therapy often causes bleeding and clotting issues. Early diagnosis and personalized anticoagulation strategies are crucial for managing hemostatic disorders during ECMO.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Critical Care Medicine
Background:
- Hemostatic disorders, including bleeding and thrombosis, are frequent complications during extracorporeal membrane oxygenation (ECMO) therapy.
- Bleeding complications during ECMO are often associated with fatal outcomes, necessitating early identification and diagnosis.
- Traditional laboratory tests may fail to detect severe coagulation disorders in ECMO patients, highlighting the need for improved diagnostic approaches.
Purpose of the Study:
- To emphasize the importance of early identification and diagnosis of hemostatic disorders in patients undergoing ECMO.
- To discuss the challenges in diagnosing and managing bleeding and thrombotic complications during ECMO.
- To advocate for a personalized approach to anticoagulation therapy based on a thorough understanding of coagulation status.
Main Methods:
- Reviewing the literature on hemostatic complications during ECMO.
- Analyzing the limitations of routine laboratory tests in ECMO patients.
- Discussing advanced diagnostic tools and monitoring strategies for anticoagulation.
Main Results:
- Bleeding is more frequent and dangerous than thrombosis during ECMO.
- Acquired von Willebrand syndrome, platelet dysfunction, coagulopathy, and silent hemolysis are key considerations for bleeding.
- Impaired intrinsic fibrinolysis may necessitate intensified anticoagulation, even in bleeding patients.
Conclusions:
- Accurate diagnosis and management of hemostatic disorders during ECMO are challenging but essential.
- Personalized anticoagulation, guided by advanced monitoring and consideration of underlying conditions, can prevent complications.
- Implementing routine screening for primary hemostasis disorders and drug monitoring is recommended for optimal patient care.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Hemodialysis II: Procedure and Complications
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Hypoxia
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...

